Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Akanda Corp. AKAN NASDAQ

NASDAQ Capital Marke • Healthcare • Drug Manufacturers - Specialty & Generic • GB • USD

SharesGrow Score
34/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Analyst Consensus — AKAN

No analyst consensus data available for AKAN.

People Also View

LFCR
LFCR
Lifecore Biomedical, Inc.
$5.38
+3.46%
 DERM
DERM
Journey Medical Corporation
$5.30
+0.76%
 GRUSF
GRUSF
Grown Rogue International Inc.
$0.32
+0.75%
 DBCCF
DBCCF
Decibel Cannabis Company Inc.
$0.09
-4.33%
 CXXIF
CXXIF
C21 Investments Inc.
$0.31
+15.12%
 BFRI
BFRI
Biofrontera Inc.
$1.06
-2.75%
 CLSH
CLSH
CLS Holdings USA, Inc.
$0.04
+0.00%
 GHSI
GHSI
Guardion Health Sciences, Inc.
$3.25
+0.93%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message